Matinas BioPharma Holdings, Inc. (MTNB) Investor Relations Documents

Matinas BioPharma Holdings, Inc. (MTNB) investor relations documents from the company's IR site: 40 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
Press releaseJul 13, 2026 • 8:00 AM EDT Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly T
2026-06-26Press releaseJun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acce
2026-04-03Press releaseDownload as PDF
2026-04-03Press releaseApr 3, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
2025-03-11Press releaseMatinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
2025-03-11Press releaseDownload as PDF
2025-02-13Press releaseMatinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to th
2025-02-13Press releaseDownload as PDF
2025-02-07Press releaseMatinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
2025-02-07Press releaseDownload as PDF
2025-01-10Press releaseMatinas BioPharma Receives NYSE Noncompliance Notice
2024-10-31Press releaseMatinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduc
Press releaseEarnings Release
2024-08-14Press releaseMatinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
2024-08-07Press releaseMatinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Upd
2024-05-09Press releaseMatinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
2024-05-07Press releaseMatinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT A
2024-05-02Press releaseMatinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Upda
2024-03-27Press releaseMatinas BioPharma Reports 2023 Financial Results and Provides a Business Update
2023-11-08Press releaseMatinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
2023-11-01Press releaseMatinas BioPharma to Webcast Conference Call to Discuss Third Quarter 2023 Financial Results and Provide a Business Upda
Press releaseMatinas BioPharma to Present at Two Investment Conferences in October 2023
2023-08-09Press releaseMatinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
2023-07-26Press releaseMatinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2023 Financial Results and Provide a Business Upd
Press releaseMatinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023
2023-05-10Press releaseMatinas BioPharma Reports First Quarter 2023 Financial Results and Provides a Business Update
2023-05-03Press releaseMatinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Upda
2023-03-15Press releaseMatinas BioPharma Reports 2022 Financial Results and Provides a Business Update
Press releaseMatinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15
2023-01-23Press releaseMatinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023
2022-11-02Press releaseMatinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
2022-10-27Press releaseMatinas BioPharma to Webcast Conference Call Discussing Third Quarter 2022 Operational and Financial Results on November
2022-08-11Press releaseMatinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
2022-07-28Press releaseMatinas BioPharma to Webcast Conference Call Discussing Second Quarter 2022 Financial and Operational Results on August
2022-05-12Press releaseMatinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
2022-05-05Press releaseMatinas BioPharma to Webcast Conference Call Discussing First Quarter 2022 Financial and Operational Results on May 12,
2022-03-08Press releaseMatinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Press releaseMatinas BioPharma to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial and Operational Resu
Press releaseMatinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, 2022
2021-11-18Press releaseMatinas BioPharma to Participate in 33rd Annual Piper Sandler Virtual Healthcare Conference

MTNB overview · MTNB earnings · MTNB financials · MTNB KPIs · MTNB ownership · MTNB peers · MTNB filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.